Reader Question: “A Mid-Tier Celebrity’s Team Just Offered Me Equity for Endorsement. Everyone Says Take It. After Your Prime and GXVE Pieces, I’m Nervous. How Do I Actually Evaluate This?”
This question landed in my inbox this week
“I’m building a supplement brand, pre-Series A, about $2M revenue. A mid-tier celebrity’s management team approached us offering equity in exchange for becoming a ‘co-founder’ reduced cash fee, meaningful stock. Everyone around me my advisors, other founders says take it, equity deals are how it’s done now. But after reading your breakdowns of Prime, GXVE, and Rhode, I’m genuinely nervous about getting this wrong. How do I actually evaluate whether THIS specific deal helps or kills my brand? I need a framework, not vibes.”
You’re right to be nervous. And you’re asking exactly the right question.
The global celebrity endorsement market reached $3.4 billion in 2025 and is projected to grow to $5.5 billion by 2032. Every talent agency, every advisor, every LinkedIn post is pushing the same message: equity beats endorsement fees.
Sometimes that’s true. Sometimes it’s the worst decision you’ll ever make as a founder. The difference isn’t the structure. It’s the specific mechanics of the deal in front of you, right now, this week.
Let me give you the actual due diligence framework before you sign anything.
The Four Levels of Celebrity Deals (And Why Level Matters More Than “Equity vs Cash”)
Before evaluating your specific offer, you need to know what level of deal you’re actually being offered.
Level 4: Equity Hybrid (The Beyoncé Model): A meaningful base guarantee combined with actual equity or equity-equivalent instruments in a product line, sub-brand, or revenue stream. The celebrity has long-term financial exposure to the brand’s success.
Level 5: Full Ownership: The celebrity bypasses endorsement entirely and builds or acquires their own brand.
Here’s the level breakdown, expanded:
Level 1: Flat Fee: Traditional endorsement. Celebrity gets paid, no equity, no long-term exposure. Low risk, low upside for both parties.
Level 2: Fee + Royalty: Celebrity gets a base fee plus a percentage of sales. Some skin in the game, but capped downside for the celebrity.
Level 3: Small Equity Stake: Celebrity receives a minority equity position (typically 1-5%) alongside a reduced fee. This is what most “equity deals” actually are.
Level 4: Equity Hybrid: A meaningful base guarantee combined with actual equity or equity-equivalent instruments, where the celebrity has genuine long-term financial exposure. This is reportedly where the 2026 Beyoncé-PepsiCo deal sits.
Level 5: Full Ownership/Co-Founder: The celebrity is a genuine operating co-founder Rhode (Hailey Bieber), Fenty (Rihanna), Cécred (Beyoncé’s own haircare line).
The critical insight from the Beyoncé-PepsiCo situation: What’s fascinating is that Beyoncé someone who could easily launch her own beverage brand tomorrow, chose to re-partner with an existing mega brand rather than compete with it. That’s a statement about the value of distribution, supply chain, and existing retail relationships that even the most powerful personal brand in the world can’t easily replicate alone.
Even Beyoncé, who has the cultural capital to launch anything, chose Level 4 over Level 5 with PepsiCo because the distribution infrastructure was worth more than full ownership.
Your first question: What level is your offer actually at? A “co-founder title with reduced fee and some equity” is very likely Level 3, not Level 5 regardless of what the term sheet calls it.
The Five-Question Framework: What to Actually Ask Before You Sign
Here’s the structured due diligence process. Work through each of these in order.
Question 1: “Does This Celebrity Have Authentic Category Credibility Or Just General Fame?”
Consumers increasingly favor brands that feel like a real extension of someone’s identity rather than a paid placement. This is the single biggest predictor of whether the deal helps or hurts you. Run this test: Could this celebrity explain, in one genuine sentence, why they personally needed this exact product before your company existed?
Passes the test:
Hailey Bieber + Rhode: had perioral dermatitis, couldn’t find products that worked
Maria Shriver + MOSH: 20 years of Alzheimer’s advocacy, couldn’t find a brain-health protein bar
Iskra Lawrence + Saltair: her entire platform was body positivity and self-acceptance
Fails the test:
Gwen Stefani + GXVE: “Everything I’ve done has led up to GXVE” — a statement about her career, not a specific unmet need
For your specific deal: Ask the celebrity’s team directly “What’s the personal story behind why they want to be involved in this specific product?” If the answer is vague (”they love wellness” or “they’ve always been interested in supplements”), that’s your first red flag. Celebrity equity, once seen as a shield, can instead amplify criticism. Consumers expect founders to be visibly involved, to articulate why they belong in a category, and to demonstrate that the brand would make sense even without their name attached.
Question 2: “What Is the Celebrity Actually Committing to Do And Is It in Writing?”
This is where the “smoke and mirrors” problem lives.
These deals aren’t always quite what they seem. While celebrities are sometimes heavily involved, there can be a little “smoke and mirrors” around terms like ‘investor.’ Equity might be handed over by a smaller brand that couldn’t otherwise afford the services of a top-tier celebrity. CNBC
Specific things to get in writing:
Minimum number of promotional posts/appearances per quarter not “regular engagement,” an actual number
Product development involvement will they attend formulation meetings? Taste-test products? Approve packaging? Or is this decorative?
Exclusivity terms can they simultaneously endorse a competitor?
Response time requirements for approvals celebrity schedules can delay product launches by months if not contractually bound
What happens if they go quiet many deals have no minimum activity clause, meaning the celebrity can technically fulfil the contract by doing nothing beyond the initial announcement
The lesson from GXVE and Flower Beauty: both had famous, genuinely talented founders attached. Both failed. The difference between “attached” and “operationally involved” is the entire ballgame and it needs to be contractually enforceable, not just verbally promised.
Question 3: “What’s the Vesting Schedule And What Happens If They Underperform or Walk Away?”
This is the question most founders forget entirely because they’re excited about the “yes.”
Just as a common early equity mistake is issuing founder shares at incorporation with no vesting schedule, which can mean a departing co-founder keeps their full stake regardless of contribution the exact same risk applies to celebrity equity.
What you need contractually:
Vesting tied to actual deliverables, not just time (e.g., “vests upon completion of 4 promotional campaigns per year,” not just “vests over 4 years regardless of activity”)
Clawback provisions if the celebrity is inactive, unresponsive, or breaches morality clauses
Clear definition of what counts as a trigger event for reduced involvement (e.g., relocation, other major deals, personal scandal)
If the celebrity’s team pushes back hard on performance-based vesting and wants pure time-based vesting regardless of activity — that’s a signal they expect to do less than you think, not more.
Question 4: “Is This Category One Where Celebrity Involvement Actually Moves the Needle Or One Where It Historically Destroys Value?”
New research just quantified something founders have intuited for years but never had data for. The Celebrity-Brand Fit Index a joint research report ranking eight consumer sectors by proprietary scoring — found that beauty, spirits, and fashion reward founder-led celebrity brands with category-leading valuations. Financial services has punished them.
Celebrity endorsers of the collapsed FTX exchange reportedly received $30 million and $18 million in now worthless equity respectively, and still face remaining securities claims after a May 2025 federal ruling.
The category-level insight matters enormously for your situation:
Supplements/wellness (your category) sits in a middle zone:
It rewards celebrity involvement when the credibility is genuine and clinical (MOSH, IM8) and punishes it hard when the celebrity is purely a marketing wrapper on a commodity product (Prime, which we’ve written about extensively).
Before you sign, ask: in MY specific category, does the data show celebrity equity correlating with better outcomes, or is this a category where celebrity involvement has a track record of destroying trust (financial products, anything regulatory-heavy, anything requiring genuine expertise the celebrity doesn’t have)?
Supplements sit close to beauty and spirits in the reward zone but only when the celebrity brings genuine credibility, not just reach.
Question 5: “What’s Your Walk-Away Plan If This Relationship Sours?”
Every framework needs to plan for the worst case, not just the best case.
The Diddy-Diageo relationship generated an estimated $50M/year for over a decade and still ended in a lawsuit, a settlement, and complete severance.
Before you sign, model these scenarios:
Scenario A: The celebrity becomes inactive. What percentage of their equity have you already given up, and what do you get back?
Scenario B: The celebrity has a personal scandal. Does your morality clause allow immediate suspension of promotional obligations and equity vesting? Is the brand name/packaging separable from their identity, or are you permanently tied to them (like Prime is permanently tied to KSI/Logan Paul)?
Scenario C: The relationship simply sours over strategic disagreements. What’s your buyout mechanism? Is there a pre-agreed formula for repurchasing their equity, or will you be negotiating from scratch during a crisis the worst possible time to negotiate?
Scenario D: They want out and you don’t. Can they sell their stake to a third party without your consent? Could a competitor end up as your celebrity’s equity buyer?
If your lawyers haven’t modelled all four of these scenarios before you sign, you’re not doing due diligence. You’re doing hope.
The Honest Answer: Should You Take the Deal?
Here’s my genuinely honest take, not a hedge:
Take it if:
The celebrity has a documented, specific, personal reason to be in your category (not general fame)
You can get performance based vesting with real teeth
The deliverables are specific and contractually enforceable
Your lawyer has walked through all four exit scenarios and you’re comfortable with each one
You would still be excited about this brand’s fundamentals even if the celebrity disappeared tomorrow
Walk away if:
The “co-founder” pitch has no specific personal story behind it just fame and reach
Their team resists performance based vesting or specific deliverable language
You’re being asked to give up more than 15 - 20% equity for a Level 3 involvement dressed up as Level 5 language
Your product/brand doesn’t have standalone merit without the celebrity attached
You feel pressure to decide quickly because “other brands want them too” genuine long-term partners don’t create artificial urgency
The most resilient celebrity brands feel less like merchandising exercises and more like extensions of a coherent personal narrative.
If you can’t articulate that coherent personal narrative in one sentence right now before the ink is dry that’s the answer to your question.
The Reality
Everyone telling you “always take equity over cash” is giving you half of the correct advice.
Equity aligns incentives when the celebrity is genuinely operationally involved and the deal structure protects you if they’re not.
Equity also creates permanent entanglement with someone whose reputation, availability, and personal choices you cannot control, in a relationship that (as Diddy and Diageo proved) can turn from $50M/year success story to bitter lawsuit even after 15 years of genuine value creation.
The question was never “equity or cash.”
The question is: does this specific celebrity, in this specific category, with this specific contract structure, create genuine long-term value alignment — or are you trading a known cost (cash fee) for an unknown, harder-to-exit liability (permanent equity entanglement with someone else’s fame)?
Run the five questions. Get the vesting terms right. Model the exit scenarios.
Then decide.
What did you decide? I’d genuinely love to know how this plays out reply and let me know once you’ve made the call.
P.P.S. If you take one thing from this entire framework: get the vesting schedule right before anything else. Institutional investors often flag a lack of proper vesting as a dealbreaker in normal founder equity splits and celebrity equity deserves exactly the same scrutiny, if not more, because you have far less influence over a celebrity’s day to day behaviour than you do over a co-founder sitting in your office. Time-based vesting with no performance triggers is the single most common mistake I see in these deals, and it’s almost always the celebrity’s team pushing for it because it guarantees them the equity regardless of whether they actually show up.